Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 46 in last 24h · 115,243 total before filter · latest 1h ago
46last 24h
1804last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A105Regulatory25Product16Analyst25
✕ clear all filtersticker: GESentiment:bullishneutralbearishshow all (incl. clickbait)
Why Honeywell’s New Earnings Guidance Isn’t as Good as It Looks
Barrons.com37d agoneutral
Why Honeywell’s New Earnings Guidance Isn’t as Good as It Looks

Honeywell Technologies made a big adjustment to its financial guidance. The automation company said late Wednesday that it now expects full-year earnings per share of between $7.90 and $8.30, from a prior range of $3.95 to $4.15. Investors should remember that Wall Street analysts don’t update numbers every day.

Genie Energy (GNE) Q1 2026 Earnings Transcript
Motley Fool93d agoneutral
Genie Energy (GNE) Q1 2026 Earnings Transcript

Michael Stein: Thank you, operator. GE's first quarter results were mixed as investments in the customer acquisition at GRE and the new business initiatives at GREW, combined with weakness in retail margins negatively impacted our bottom line despite record quarterly revenue. At GRE, challenging commodity market conditions in the first 2 months of the quarter caused by extreme cold compressed margins for both electricity and gas.

GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip
24/7 Wall St.107d agobearish
GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip

GE HealthCare (NASDAQ: GEHC) currently trades at $59.49, well below the Wall Street consensus price target of $89.74. That implies upside of roughly 50.8% if the analysts are right. GE HealthCare is the medical imaging and diagnostics business spun from General Electric, with about $20.6 billion in annual revenue across Advanced Imaging Solutions, Patient Care ... GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip

GE HealthCare Technologies Q1 Earnings Call Highlights
MarketBeat108d agoneutral
GE HealthCare Technologies Q1 Earnings Call Highlights

GE HealthCare Technologies (NASDAQ:GEHC) reported first-quarter 2026 results that management said landed at the high end of expectations on revenue, while profits and cash flow guidance for the full year were reduced to reflect higher input costs and a first-quarter supplier-related recall in Pharma